Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
EOM Pharmaceutical Holdings, Inc. (IMUC) had Stock-Based Compensation of $0.49M for the most recently reported fiscal year, ending 2017-12-31.
| Income Statement Financials | |
-- |
|
$-17.68M |
|
-- |
|
-- |
|
$21.15M |
|
$-21.15M |
|
$6.84M |
|
$-14.31M |
|
$-14.31M |
|
$-14.31M |
|
$-14.31M |
|
$-14.31M |
|
$-14.31M |
|
$-21.15M |
|
$-21.11M |
|
1.44M |
|
1.44M |
|
$-12.30 |
|
$-12.30 |
|
| Balance Sheet Financials | |
$7.01M |
|
$0.00M |
|
$0.00M |
|
$7.01M |
|
$2.36M |
|
-- |
|
-- |
|
$2.36M |
|
$4.65M |
|
$4.65M |
|
$4.65M |
|
4.19M |
|
| Cash Flow Statement Financials | |
$-16.67M |
|
$0.00M |
|
$11.86M |
|
$11.44M |
|
$6.63M |
|
$-4.81M |
|
|
Stock-Based Compensation |
$0.49M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.97 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.67M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-307.89% |
|
-307.89% |
|
-204.19% |
|
-307.89% |
|
$1.11 |
|
$-11.57 |
|
$-11.57 |
|